Notes
The study was sponsored by Teva Neuroscience.
Reference
Johnson SJ, et al. An economic model of Parkinson's disease: Implications for slowing progression in the United States. Movement Disorders : 12 Feb 2013. Available from: URL: http://dx.doi.org/10.1002/mds.25328
Rights and permissions
About this article
Cite this article
Slowing PD progression "substantial value". PharmacoEcon Outcomes News 673, 6 (2013). https://doi.org/10.1007/s40274-013-0204-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0204-1